Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 39

1.

Context Based Emotion Recognition using EMOTIC Dataset.

Kosti R, Alvarez J, Recasens A, Lapedriza A.

IEEE Trans Pattern Anal Mach Intell. 2019 May 14. doi: 10.1109/TPAMI.2019.2916866. [Epub ahead of print]

PMID:
31095475
2.

Targeting Cancer Cell Dormancy.

Recasens A, Munoz L.

Trends Pharmacol Sci. 2019 Feb;40(2):128-141. doi: 10.1016/j.tips.2018.12.004. Epub 2019 Jan 3. Review.

PMID:
30612715
3.

Complications of continuous catheter analgesia for postoperative pain management in a tertiary care hospital. Incidence of technical complications and alternative analgesia methods used.

Recasens A, Hidalgo A, Faulí A, Dürsteler C, Arguis MJ, Gomar C.

Rev Esp Anestesiol Reanim. 2019 Feb;66(2):84-92. doi: 10.1016/j.redar.2018.08.008. Epub 2018 Nov 23. English, Spanish.

PMID:
30473391
4.

Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.

Recasens A, Carballo-Carbajal I, Parent A, Bové J, Gelpi E, Tolosa E, Vila M.

Acta Neuropathol Commun. 2018 Feb 8;6(1):8. doi: 10.1186/s40478-018-0509-1.

5.

Selective α-Synuclein Knockdown in Monoamine Neurons by Intranasal Oligonucleotide Delivery: Potential Therapy for Parkinson's Disease.

Alarcón-Arís D, Recasens A, Galofré M, Carballo-Carbajal I, Zacchi N, Ruiz-Bronchal E, Pavia-Collado R, Chica R, Ferrés-Coy A, Santos M, Revilla R, Montefeltro A, Fariñas I, Artigas F, Vila M, Bortolozzi A.

Mol Ther. 2018 Feb 7;26(2):550-567. doi: 10.1016/j.ymthe.2017.11.015. Epub 2017 Nov 29.

6.

In vivo models of alpha-synuclein transmission and propagation.

Recasens A, Ulusoy A, Kahle PJ, Di Monte DA, Dehay B.

Cell Tissue Res. 2018 Jul;373(1):183-193. doi: 10.1007/s00441-017-2730-9. Epub 2017 Nov 29. Review.

PMID:
29185072
7.

Continuous positive airway pressure improves sleep quality, but not glycaemic control, in patients with poorly controlled long-standing type 2 diabetes.

Torrella M, Castells I, Gimenez-Perez G, Recasens A, Miquel M, Simó O, Barbeta E, Sampol G.

Diabetes Metab. 2017 Dec;43(6):547-549. doi: 10.1016/j.diabet.2017.08.006. Epub 2017 Oct 10. No abstract available.

PMID:
29029945
8.

Role of microRNAs in the Regulation of α-Synuclein Expression: A Systematic Review.

Recasens A, Perier C, Sue CM.

Front Mol Neurosci. 2016 Nov 21;9:128. eCollection 2016. Review.

9.

Use of communication technologies by people with type 1 diabetes in the social networking era. A chance for improvement.

Giménez-Pérez G, Recasens A, Simó O, Aguas T, Suárez A, Vila M, Castells I.

Prim Care Diabetes. 2016 Apr;10(2):121-8. doi: 10.1016/j.pcd.2015.09.002. Epub 2015 Oct 5.

PMID:
26428527
10.

Intermittent hypoxia is an independent marker of poorer glycaemic control in patients with uncontrolled type 2 diabetes.

Torrella M, Castells I, Gimenez-Perez G, Recasens A, Miquel M, Simó O, Barbeta E, Sampol G.

Diabetes Metab. 2015 Sep;41(4):312-8. doi: 10.1016/j.diabet.2015.01.002. Epub 2015 Feb 3.

PMID:
25662841
11.

Alpha-synuclein spreading in Parkinson's disease.

Recasens A, Dehay B.

Front Neuroanat. 2014 Dec 18;8:159. doi: 10.3389/fnana.2014.00159. eCollection 2014. Review.

12.

Does health education affect BMI? Evidence from a school-based randomised-control trial.

Mora T, Llargués E, Recasens A.

Econ Hum Biol. 2015 Apr;17:190-201. doi: 10.1016/j.ehb.2014.11.001. Epub 2014 Nov 22.

PMID:
25483772
13.

BAX channel activity mediates lysosomal disruption linked to Parkinson disease.

Bové J, Martínez-Vicente M, Dehay B, Perier C, Recasens A, Bombrun A, Antonsson B, Vila M.

Autophagy. 2014 May;10(5):889-900. doi: 10.4161/auto.28286. Epub 2014 Mar 26.

14.

Nutritional support in patients with systemic sclerosis.

Ortiz-Santamaria V, Puig C, Soldevillla C, Barata A, Cuquet J, Recasens A.

Reumatol Clin. 2014 Sep-Oct;10(5):283-7. doi: 10.1016/j.reuma.2013.12.011. Epub 2014 Mar 4.

15.

Lewy body extracts from Parkinson disease brains trigger α-synuclein pathology and neurodegeneration in mice and monkeys.

Recasens A, Dehay B, Bové J, Carballo-Carbajal I, Dovero S, Pérez-Villalba A, Fernagut PO, Blesa J, Parent A, Perier C, Fariñas I, Obeso JA, Bezard E, Vila M.

Ann Neurol. 2014 Mar;75(3):351-62. doi: 10.1002/ana.24066. Epub 2014 Feb 18.

PMID:
24243558
16.

Optic atrophy 1 mediates mitochondria remodeling and dopaminergic neurodegeneration linked to complex I deficiency.

Ramonet D, Perier C, Recasens A, Dehay B, Bové J, Costa V, Scorrano L, Vila M.

Cell Death Differ. 2013 Jan;20(1):77-85. doi: 10.1038/cdd.2012.95. Epub 2012 Aug 3.

17.

Medium-term evaluation of an educational intervention on dietary and physical exercise habits in schoolchildren: the Avall 2 study.

Llargués E, Recasens A, Franco R, Nadal A, Vila M, Pérez MJ, Recasens I, Salvador G, Serra J, Roure E, Castell C.

Endocrinol Nutr. 2012 May;59(5):288-95. doi: 10.1016/j.endonu.2012.03.002. Epub 2012 Apr 20.

PMID:
22521298
18.

Assessment of a school-based intervention in eating habits and physical activity in school children: the AVall study.

Llargues E, Franco R, Recasens A, Nadal A, Vila M, Pérez MJ, Manresa JM, Recasens I, Salvador G, Serra J, Roure E, Castells C.

J Epidemiol Community Health. 2011 Oct;65(10):896-901. doi: 10.1136/jech.2009.102319. Epub 2011 Mar 12.

19.

Pathogenic lysosomal depletion in Parkinson's disease.

Dehay B, Bové J, Rodríguez-Muela N, Perier C, Recasens A, Boya P, Vila M.

J Neurosci. 2010 Sep 15;30(37):12535-44. doi: 10.1523/JNEUROSCI.1920-10.2010.

20.

[Weight, dietary patterns and exercise habits in first-year primary school children: the AVall study].

Llargués E, Franco R, Recasens A, Nadal A, Vila M, José Pérez M, Martínez-Mateo F, Recasens I, Salvador G, Serra J, Castells C.

Endocrinol Nutr. 2009 Jun-Jul;56(6):287-92. doi: 10.1016/S1575-0922(09)71943-6. Spanish.

PMID:
19695510
21.

[Not Available].

Simó O, Yetano V, Castells I, Recasens A, Serrano A.

Endocrinol Nutr. 2008 Apr;55(4):189-90. doi: 10.1016/S1575-0922(08)70664-8. Epub 2008 Oct 14. English, Spanish. No abstract available.

PMID:
22975459
22.

Cardiovascular risk factor management is poorer in diabetic patients with undiagnosed peripheral arterial disease than in those with known coronary heart disease or cerebrovascular disease. Results of a nationwide study in tertiary diabetes centres.

González-Clemente JM, Piniés JA, Calle-Pascual A, Saavedra A, Sánchez C, Bellido D, Martín-Folgueras T, Moraga I, Recasens A, Girbés J, Sánchez-Zamorano MA, Mauricio D; PADiD Study Group.

Diabet Med. 2008 Apr;25(4):427-34. doi: 10.1111/j.1464-5491.2008.02402.x. Epub 2008 Mar 13.

PMID:
18341592
23.

[Pituitary apoplexy following treatment for acute coronary syndrome].

Simó O, Castells I, Recasens A, Yetano V.

Med Clin (Barc). 2006 Sep 30;127(12):477. Spanish. No abstract available.

PMID:
17040638
24.

An outbreak of food poisoning due to a genogroup I norovirus.

Sala MR, Cardeñosa N, Arias C, Llovet T, Recasens A, Domínguez A, Buesa J, Salleras L.

Epidemiol Infect. 2005 Feb;133(1):187-91.

25.

[The use of alternative therapies for the treatment of obesity].

Goday A, Recasens A, Serra M, Moix SS.

Med Clin (Barc). 1998 Oct 17;111(12):478-9. Spanish. No abstract available.

PMID:
9842535
26.

[Iatrogenic hyperthyroidism secondary to weight loss medication. Predictive factors for their precocious detention].

Goday A, Recasens A, Manresa JM, Vila J, Moix S.

An Med Interna. 1998 May;15(5):245-9. Spanish.

PMID:
9629770
27.

[Iatrogenic hyperthyroidism. Report of an outbreak].

Goday A, Recasens A, Méndez M, Yetano V, Guirado P.

Med Clin (Barc). 1995 Nov 18;105(17):658-60. Spanish.

PMID:
8558966
28.

[Dietary habits of 2 populations of the province of Barcelona (III): energy consumption and macronutrients].

Ramón JM, Micaló T, Escolano L, Pe P, Recasens A, Romera M.

Med Clin (Barc). 1994 Oct 29;103(14):525-8. Spanish.

PMID:
7799663
29.
30.

[Dietary habits of 2 populations of the province of Barcelona (I): design and validation of a semiquantitative questionnaire of frequency of food consumption].

Ramón JM, Micaló T, Benítez D, Escolano L, Pe P, Recasens A, Romera M.

Med Clin (Barc). 1994 Jun 4;103(1):1-4. Spanish.

PMID:
8051958
31.

[Care for the diabetic patient in Catalonia. A study of a population sample].

Figuerola D, Recasens A, Castell C, Lloveras G.

Med Clin (Barc). 1992 Jun 13;99(3):90-5. Spanish.

PMID:
1630205
32.

Prediabetes in Mediterranean first-degree relatives of patients with IDDM.

Montańa E, Nonell F, Fernandez J, Recasens A, Gomis R.

Diabetes Care. 1989 Jun;12(6):440-1. No abstract available.

PMID:
2731466
33.

Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren.

Bergua M, Solé J, Marion G, Perez MC, Recasens A, Fernàndez J, Casamitjana R, Gomis R.

Diabetologia. 1987 Sep;30(9):724-6.

PMID:
3322914
34.

Nocturnal insulin and C-peptide rhythms in normal subjects.

Levy I, Recasens A, Casamitjana R, Figuerola D.

Diabetes Care. 1987 Mar-Apr;10(2):148-51.

PMID:
3556102
35.

[The dawn phenomenon could be due to nictemeral rhythms in the peripheral metabolism of insulin].

Levy I, Bergua M, Recasens A, Gutiérrez A, Rodríguez MD, Vidal N, Capillas R, Goday A, Casamitjana R, Guillén M, et al.

Med Clin (Barc). 1986 May 31;87(1):6-9. Spanish. No abstract available.

PMID:
3736203
36.

[Thyroid function in adults with mental retardation].

Angel M, López-Moreiras N, Cabrer J, Recasens A.

Med Clin (Barc). 1985 Nov 16;85(16):656-8. Spanish. No abstract available.

PMID:
4079559
37.

[The fallacy of glycosylated hemoglobin].

Recasens A, Reynals E, Aguilar JL, Figuerola D.

Med Clin (Barc). 1985 Jun 8;85(2):82-3. Spanish. No abstract available.

PMID:
4021621
38.

[Spontaneous pneumomediastinum associated with anorexia nervosa].

Recasens A, Angel M, Xaubet A, Halperin I.

Med Clin (Barc). 1985 Mar 9;84(9):377. Spanish. No abstract available.

PMID:
3990425
39.

[McCune-Albright syndrome associated with hyperthyroidism].

Recasens A, Cabrer J, Angel M, Calderón MD, Vilardell E.

Med Clin (Barc). 1985 Feb 23;84(7):277-9. Spanish. No abstract available.

PMID:
3982147

Supplemental Content

Loading ...
Support Center